Is MRK up or down today?
MRK is down 1.19% today, last at 147.74. This stock moved -1.19% versus the prior close.
MRK · Merck & Co.
MRK (Merck & Co.) is trading at 147.74, down 1.19% on the session. MRK sits at the 88% mark of its 52-week range, carries a 14-day RSI of 54, and trades above its 50-day average. Over the past month it is up 2.73%.
Leading the coverage: “Merck (MRK) Pushes Ahead With Oral HIV Regimens And 2027 FDA Review” (Simply Wall St., 19m ago).
MRK trades on a trailing P/E of 116.3 and is running 3.19% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
MRK is down 1.19% today, last at 147.74. This stock moved -1.19% versus the prior close.
Leading the coverage: “Merck (MRK) Pushes Ahead With Oral HIV Regimens And 2027 FDA Review” (Simply Wall St., 19m ago). Dominant story: Merck (MRK) Pushes Ahead With Oral HIV Regimens And 2027 FDA Review (1 source, neutral) RSI is 54 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Merck (MRK) Pushes Ahead With Oral HIV Regimens And 2027 FDA Review
Cantor Fitzgerald raises Merck stock price target on solid quarter By Investing.com - Investing.com Canada
MRK Maintained by Cantor Fitzgerald -- Price Target Raised to $1 - GuruFocus
Merck & Co., Inc. $MRK Stock Position Increased by Trek Financial LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Raised at Cantor Fitzgerald - MarketBeat